GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy
Danrong Hu, Omar Mezghrani, Lei Zhang, Yi Chen, Xue Ke, Tianyuan Ci Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, People’s Republic of China Abstract: Novel breast carcinoma dual-targeted redox-responsive nanoparticles (...
Guardado en:
Autores principales: | Hu DR, Mezghrani O, Zhang L, Chen Y, Ke X, Ci TY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c591e6594b364e67ab69877b516ecf2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery
por: Yang YS, et al.
Publicado: (2018) -
The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin
por: Wang J, et al.
Publicado: (2016) -
Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy
por: Yang Y, et al.
Publicado: (2020) -
Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs
por: Liu J, et al.
Publicado: (2018) -
Tumor microenvironment dual-responsive core–shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA
por: Wang T, et al.
Publicado: (2017)